18.90
0.00
(0.00%)
As of 8:05:02 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 3 | 3 |
| Avg. Estimate | 210.48M | 215.43M | 866.35M | 908.26M |
| Low Estimate | 209.4M | 213.3M | 860.7M | 900.5M |
| High Estimate | 211M | 216.43M | 870.1M | 913.49M |
| Year Ago Sales | 154.43M | 152.85M | 808.54M | 866.35M |
| Sales Growth (year/est) | 36.30% | 40.94% | 7.15% | 4.84% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 1HI.F | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.77% | 9.23% | 14.19% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Underweight to Underweight | 4/9/2025 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/8/2025 |
| Maintains | JP Morgan: Underweight to Underweight | 2/3/2025 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 2/3/2025 |
| Maintains | Goldman Sachs: Sell to Sell | 2/3/2025 |
| Maintains | Piper Sandler: Neutral to Neutral | 2/3/2025 |